Iloperidone was a big drug for them at the time they effectively shorted their company's stock from $65 to $2. If they thought the drug was worthwhile, do you think they would have created that position?
Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.